Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 008 20)

Label (51655 008 20)
This is a prescription medication with NDC 51655-008-20, containing 20 orally disintegrating tablets of Ondansetron, USP. The tablets should not be removed from the blister pack until immediately before use, which should follow the dosage specified in the package insert. The medication must be stored in its original container at temperatures between 20° - 25°C (68° - 77°F) which constitutes USP controlled room temperature. Phenylketonurics, who are sensitive to Phenylalanine, should not take this medication. This product meets USP disintegration test 2 and each of the 20 tablets contains 4mg of ondansetron. The packaging material should not be opened if torn, broken or missing. The medication should be kept out of the reach of children and provided in child-resistant containers for outpatient use. This particular package was repackaged by Northwind Pharmaceuticals in Indianapolis, IN 46203, with a 0000000000 lot and an expiration date of 00/00/0000.*
FDA Label Image
FDA Label Image

Structure-base (Structure Base)

FDA Label Image

Structure-hcl (Structure HCl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.